The Positron Emission Tomography Ligand DAA1106 Binds With High Affinity to Activated Microglia in Human Neurological Disorders
Open Access
- 1 October 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 67 (10), 1001-1010
- https://doi.org/10.1097/nen.0b013e318188b204
Abstract
Chronic microglial activation is an important component of many neurological disorders, and imaging activated microglia in vivo will enable the detection and improved treatment of neuroinflammation. 1-(2-Chlorphenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline-carbox-amide (PK11195), a peripheral benzodiazepine receptor ligand, has been used to image neuroinflammation, but the extent to which PK11195 binding distinguishes activated microglia and reactive astrocytes is unclear. Moreover, PK11195 may lack sufficient sensitivity for detecting mild neuroinflammation. We hypothesized that N-(2,5-dimethoxybenzyl)-N-(4-fluoro-2-phenoxyphenyl) acetamide (DAA1106), a new ligand that binds specifically to peripheral benzodiazepine receptor, binds to activated microglia in human neurological diseases with higher affinity than does PK11195. We therefore compared the pharmacological binding properties of [3H](R)-PK11195 and [3H]DAA1106 in postmortem tissues from patients with cerebral infarcts, amyotrophic lateral sclerosis, Alzheimer disease, frontotemporal dementia, and multiple sclerosis (n = 10 each). In all diseases, [3H]DAA1106 showed a higher binding affinity as reflected by lower dissociation constant (KD) values than that of [3H](R)-PK11195. Moreover, specific binding of both ligands correlated with the presence of activated microglia identified by immunohistochemistry in situ. We conclude that 1) ligands that bind peripheral benzodiazepine receptor mainly label activated microglia in human neurological disorders and that 2) DAA1106 may possess binding characteristics superior to those of PK11195, which may be beneficial for in vivo positron emission tomography imaging.Keywords
This publication has 44 references indexed in Scilit:
- The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds to activated and infected brain macrophages in areas of synaptic degeneration: Implications for PET imaging of neuroinflammation in lentiviral encephalitisNeurobiology of Disease, 2008
- Microglial activation in presymptomatic Huntington's disease gene carriersBrain, 2007
- Assessment of microglial activation in mild cognitive impairment using [11C](R)-PK11195 and PETNeuroImage, 2006
- The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imagingProgress in Neurobiology, 2006
- Up-regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brainEuropean Journal of Neuroscience, 2006
- Intrinsic Activated Microglia Map to the Peri-infarct Zone in the Subacute Phase of Ischemic StrokeStroke, 2006
- In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathyGut, 2006
- Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatumNeurobiology of Disease, 2005
- Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localizationBrain, 2004
- Monitoring by PET of macrophage accumulation in brain after ischaemic strokeThe Lancet, 1992